Skip to content

Clinical trials

Terminated Brain Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Diseases Status: Terminated Country / region: France Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20142
20151
20161
20172
20182
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Affiris AG1
Genentech, Inc.1
GlaxoSmithKline1
Hoffmann-La Roche1
Remedy Pharmaceuticals, Inc.1
Shire1
TauRx Therapeutics Ltd1
University Hospital, Montpellier1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Diseases11
Alzheimer Disease8
Central Nervous System Diseases8
Dementia8
Nervous System Diseases7
Mental Disorders6
Neurodegenerative Diseases6
Tauopathies5
Neurocognitive Disorders4
Brain Diseases, Metabolic, Inborn1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.